Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Expect the international business including CDMO business to pick-up in the second half of the financial year
To co-develop and co-commercialize MK-6070, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager, worldwide except for Japan where Merck retains exclusive rights
Being the first approved applicant, Lupin is eligible for 180 days of CGT exclusivity
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
Subscribe To Our Newsletter & Stay Updated